enow.com Web Search

  1. Ads

    related to: hep c new treatment options for multiple myeloma cancer

Search results

  1. Results from the WOW.Com Content Network
  2. High-dose chemotherapy - Wikipedia

    en.wikipedia.org/wiki/High-dose_chemotherapy

    This treatment method is commonly linked with blood cancers like multiple myeloma, Hodgkin's lymphoma, and non-Hodgkin's lymphoma. It is also used in solid tumors such as germ cell tumors and certain high risk or recurrent breast cancers. Multiple myeloma, a type of plasma cell cancer [3] is an indication for HDC. Typically it follows stem cell ...

  3. Multiple Myeloma Research Consortium - Wikipedia

    en.wikipedia.org/wiki/Multiple_Myeloma_Research...

    The mission of the Multiple Myeloma Research Consortium (MMRC) is to champion collaboration with and integration across academia and industry and to focus on speed and innovation to bring the most promising multiple myeloma treatments to patients faster.

  4. Chemotherapy regimen - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy_regimen

    The majority of drugs used in cancer chemotherapy are cytostatic, many via cytotoxicity. A fundamental philosophy of medical oncology , including combination chemotherapy, is that different drugs work through different mechanisms, and that the results of using multiple drugs will be synergistic to some extent.

  5. What People Who Inject Drugs Should Know about Hepatitis C ...

    www.aol.com/people-inject-drugs-know-hepatitis...

    Back then, your treatment options were 26 to 52 weeks of weekly injections of a medication called interferon, usually with an additional daily oral medication called ribavirin.

  6. Will New Hepatitis C Treatments Alter the Outlook for These ...

    www.aol.com/2013/10/25/will-new-hepatitis-c...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Melphalan flufenamide - Wikipedia

    en.wikipedia.org/wiki/Melphalan_flufenamide

    In the United States before market withdrawal, melphalan flufenamide was indicated in combination with dexamethasone for the treatment of adults with relapsed or refractory multiple myeloma, with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one ...

  1. Ads

    related to: hep c new treatment options for multiple myeloma cancer